Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Controlled Multicentre Study of Albumin Replacement Therapy in Septic Shock

NCT03869385 is registered in ClinicalTrials.gov with Jena University Hospital as lead sponsor.

NCT NCT03869385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03869385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Controlled Multicentre Study of Albumin Replacement Therapy in Septic Shock
Lead sponsor
Jena University Hospital
Phase
Phase 3
Overall status
Terminated
Start date
October 21, 2019
Completion date
June 13, 2023
Enrollment
440 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock